Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Theo Rispens

Showing results (121-130 of 304) with videos related to

Pageof 31
Sort By:
Frontiers in Immunology|May 1, 2018
Variable Domain <i>N</i>-Linked Glycans Acquired During Antigen-Specific Immune Responses Can Contribute to Immunoglobulin G Antibody StabilityFleur S van de Bovenkamp, Ninotska I L Derksen, Mariëlle J van Breemen, et al.
Multiple Sclerosis and Related Disorders|August 3, 2024
Subcutaneous administration of natalizumab can lead to lower drug concentrations compared to intravenous administrationLiza M Y Gelissen, Sam Loveless, Alyssa A Toorop, et al.
Clinical and Experimental Rheumatology|April 4, 2019
Antidrug antibody detection for adalimumab depends on the type of assay used: an experimental approach to help clinicians interpret diagnostic dataJill Ruwaard, Anneke F Marsman, Michael T Nurmohamed, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 28, 2020
Unraveling the Effect of a Potentiating Anti-Factor H Antibody on Atypical Hemolytic Uremic Syndrome-Associated Factor H VariantsGillian Dekkers, Mieke C Brouwer, Jorn Jeremiasse, et al.
Frontiers in Immunology|September 28, 2018
<i>In vitro</i>-Induced Human IL-10<sup>+</sup> B Cells Do Not Show a Subset-Defining Marker Signature and Plastically Co-express IL-10 With Pro-Inflammatory CytokinesLaura C Lighaam, Peter-Paul A Unger, David W Vredevoogd, et al.
The Journal of Dermatological Treatment|April 26, 2023
The clinical relevance of dupilumab serum concentration in patients with atopic dermatitis: a two-center prospective cohort studyAngela L Bosma, Louise A A Gerbens, Hajar El Khattabi, et al.
Frontiers in Immunology|May 16, 2022
CD45RB Glycosylation and Ig Isotype Define Maturation of Functionally Distinct B Cell Subsets in Human Peripheral BloodJana Koers, Sabrina Pollastro, Simon Tol, et al.
Frontiers in Immunology|November 24, 2025
Biochemical analysis reveals aberrant and variable Immunoglobulin M composition in Waldenström macroglobulinemia and IgM monoclonal gammopathy of unknown significanceNienke Oskam, Wouter Verhaar, Pleuni Ooijevaar-de Heer, et al.
Annals of the Rheumatic Diseases|February 4, 2015
Increased IgG4 responses to multiple food and animal antigens indicate a polyclonal expansion and differentiation of pre-existing B cells in IgG4-related diseaseEmma L Culver, Ellen Vermeulen, Mateusz Makuch, et al.
Rheumatology (Oxford, England)|March 4, 2025
Belimumab concentrations and immunogenicity in relation to drug effectiveness and safety in SLE within a Swedish real-world settingAlvaro Gomez, Tomas Walhelm, Floris C Loeff, et al.
Pageof 31

Showing results (121-130 of 304) with videos related to

Sort By:
Pageof 31
Frontiers in Immunology|May 1, 2018
Variable Domain <i>N</i>-Linked Glycans Acquired During Antigen-Specific Immune Responses Can Contribute to Immunoglobulin G Antibody StabilityFleur S van de Bovenkamp, Ninotska I L Derksen, Mariëlle J van Breemen, et al.
Multiple Sclerosis and Related Disorders|August 3, 2024
Subcutaneous administration of natalizumab can lead to lower drug concentrations compared to intravenous administrationLiza M Y Gelissen, Sam Loveless, Alyssa A Toorop, et al.
Clinical and Experimental Rheumatology|April 4, 2019
Antidrug antibody detection for adalimumab depends on the type of assay used: an experimental approach to help clinicians interpret diagnostic dataJill Ruwaard, Anneke F Marsman, Michael T Nurmohamed, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 28, 2020
Unraveling the Effect of a Potentiating Anti-Factor H Antibody on Atypical Hemolytic Uremic Syndrome-Associated Factor H VariantsGillian Dekkers, Mieke C Brouwer, Jorn Jeremiasse, et al.
Frontiers in Immunology|September 28, 2018
<i>In vitro</i>-Induced Human IL-10<sup>+</sup> B Cells Do Not Show a Subset-Defining Marker Signature and Plastically Co-express IL-10 With Pro-Inflammatory CytokinesLaura C Lighaam, Peter-Paul A Unger, David W Vredevoogd, et al.
The Journal of Dermatological Treatment|April 26, 2023
The clinical relevance of dupilumab serum concentration in patients with atopic dermatitis: a two-center prospective cohort studyAngela L Bosma, Louise A A Gerbens, Hajar El Khattabi, et al.
Frontiers in Immunology|May 16, 2022
CD45RB Glycosylation and Ig Isotype Define Maturation of Functionally Distinct B Cell Subsets in Human Peripheral BloodJana Koers, Sabrina Pollastro, Simon Tol, et al.
Frontiers in Immunology|November 24, 2025
Biochemical analysis reveals aberrant and variable Immunoglobulin M composition in Waldenström macroglobulinemia and IgM monoclonal gammopathy of unknown significanceNienke Oskam, Wouter Verhaar, Pleuni Ooijevaar-de Heer, et al.
Annals of the Rheumatic Diseases|February 4, 2015
Increased IgG4 responses to multiple food and animal antigens indicate a polyclonal expansion and differentiation of pre-existing B cells in IgG4-related diseaseEmma L Culver, Ellen Vermeulen, Mateusz Makuch, et al.
Rheumatology (Oxford, England)|March 4, 2025
Belimumab concentrations and immunogenicity in relation to drug effectiveness and safety in SLE within a Swedish real-world settingAlvaro Gomez, Tomas Walhelm, Floris C Loeff, et al.
Pageof 31